Dual-action approach targeting inflammation shows potential as type 1 diabetes treatment

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of type 1 diabetes by targeting an inflammation-related protein known to drive the disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup